Treatment of papulopustular rosacea with ivermectin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10206939
APP PUB NO 20180264021A1
SERIAL NO

15988368

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALDERMA HOLDING SA1814 LA TOUR-DE-PEILZ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Briantais, Philippe Antibes, FR 12 21
Chappuis, Jean-Paul Valbonne, FR 15 36
Graeber, Michael Lawrenceville, US 65 214
Jacovella, Jean Antibes, FR 18 36
Kaoukhov, Alexandre Newport Beach, US 45 128
Poncet, Michel Mougins, FR 22 56
Salin, Laurence La Roquette sur Siagne, FR 16 31

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 19, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 19, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00